Skip to main content
Premium Trial:

Request an Annual Quote

Minnesota s Blizzard Gets New CEO

NEW YORK, July 16-The president of microarray scanner startup Blizzard Genomics, James Adam, will now also serve as CEO, the company said yesterday.


Former CEO Martin Blumenfeld will continue as chief scientific officer and chair of the board of directors.


Adam joined the company in March 2001.


Blizzard, based in St. Paul, Minn., is developing a low-cost LED-based chip scannerthat it hopes to have on the market by the end of the year.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.